Pan-Cancer Analyses of the Tumor Microenvironment Reveal That Ubiquitin-Conjugating Enzyme E2C Might Be a Potential Immunotherapy Target

Table 3

StromalScore and ImmuneScore relevance analyses.

Cancer type	StromalScore ( value)	ImmuneScore ( value)	Cancer type	StromalScore ( value)	ImmuneScore ( value)
ACC	0.039206664	0.043914766	LUSC	<0.0001
BLCA	0.02576853	0.344845775	MESO	0.350009942	0.987592237
BRCA	<0.0001	0.032604764	OV	0.022205613	0.059919863
CESC		0.000526389	PAAD		0.000328994
CHOL	0.424329989	0.888603589	PCPG	0.469691421	0.091593433
COAD			PRAD	0.797111161	0.452014481
DLBC	0.656490741	0.010779696	READ	0.000502512
ESCA	0.025103976	0.077152512	SARC	0.001291543	0.471153803
GBM			SKCM	0.001624749	0.246571531
HNSC		0.033907848	STAD	<0.0001
KICH	0.027436293	0.030604563	TGCT	0.000812132	0.01318386
KIRC	0.0125631		THCA	<0.0001	<0.0001
KIRP	0.839715612	0.765465463	THYM		0.001692186
LAML	0.489788421	0.185129925	UCEC
LGG	0.029818407	0.001691075	UCS	0.131139903	0.164492641
LIHC		0.670876508	UVM	0.608394004	0.848009961
LUAD	0.000178847	0.059633661